U3 Pharma
U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Professor Axel Ullrich. Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.
View Top Employees for U3 Pharma
|
Industry | Biotechnology |
|
Location | Madrid, Madrid, Spain |
|
Employees | 4 |
|
HQ | 22 Fraunhoferstraße |
|
Funding | 14,350,000 EUR |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Industry | Biotechnology |
|
|
Location | Madrid, Madrid, Spain |
|
|
Employees | 4 |
|
linkedin.com/company/u3-pharma | |
|
|
HQ | 22 Fraunhoferstraße |
|
|
Funding | 14,350,000 EUR |
Top Competitors for U3 Pharma
U3 Pharma Questions
Where are U3 Pharma's headquarters?
U3 Pharma's headquarters are in 22 Fraunhoferstraße
How many employees are working in U3 Pharma right now?
U3 Pharma has
4 employees.
View the Email and Phone Numbers for all 4 working at U3 Pharma.
What is U3 Pharma's industry?
U3 Pharma's industry is
Biotechnology
Who are U3 Pharma's top competitors?
U3 Pharma's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are U3 Pharma's categories?
U3 Pharma's categories are Biotechnology, Health Care
What is U3 Pharma's location?
U3 Pharma's location is
Madrid, Madrid, Spain
What is U3 Pharma's funding?
U3 Pharma's funding is 14,350,000 EUR
What is U3 Pharma's current status?
U3 Pharma's current status is acquired
